Eficacia y seguridad del manejo intervencionista guiado por ultrasonografia en pacientes con dolor cronico: seguimiento a una cohorte.
Pain is a frequent cause of visits to the doctor and there is an increasing need to provide optimal and safe treatment. The use of ultrasonography in interventional analgesia has become increasingly relevant for pain management in the last 10 years. (1)
Ultrasound guidance improves the safety of regional anesthesia because it reduces the volume of the local anesthetic agent required and hence lowers the incidence of systemic toxicity, shortens the time to perform the block, reduces the number of needle insertions and provides faster onset of action. Moreover, it reduces the risk of accidental puncture of other neighboring structures because it enables the visualization of the peripheral nerves, of the surrounding structures and the needle. The disadvantages are few but important, such as availability and the need for additional raining. (2-6)
There is increasing certainty about the importance of using ultrasonography in interventional analgesia to complement other more extensively used techniques--i.e. fluoroscopy--and about the need to promote ultrasound training in the anesthesia graduate programs and pain management subspecialties at various universities around the world and as a topic of general interest at international congresses.
Consequently, a trial was designed to answer the question: Is ultrasound-guided interventional management effective and safe for chronic pain patients?
To determine the clinical efficacy and safety of ultrasound-guided interventional management in chronic pain patients.
* To describe the study population in terms of the socio-demographic characteristics.
* To determine the major blocks performed in chronic pain patients.
* To identify any changes in the pain intensity as described by the patients before and after treatment.
* To assess the efficacy of interventional therapy in terms of pain relief.
* To assess the association between pain relief and sex, diagnosis of fibromyalgia and prior oral pharmacological treatments.
* To determine the safety of the blocks in terms of the occurrence of complications.
Materials and methods
With the approval of the Ethics Committee, a descriptive follow-up trial of a cohort of chronic pain patients that received ultrasound-guided interventional therapy, using 0.5% bupivacaine without epinephrine plus 4 mg of dexamethasone for a peripheral nerve block or an intra-articular block with 0.5% bupivacaine without epinephrine plus 40 mg of methylprednisolone acetate, was undertaken. A portable General Electric LOGIQe[R] scanner was used, with linear transducers (7-12 MHz) and convex transducers (2-5 MHz). All patients were evaluated prior to the procedure and one month later. The procedures were done five to ten days following the initial evaluation. At every control the pain intensity was measured using the visual analog scale (VAS) and during the one-month follow-up visit the patients were asked about the VAS pain intensity two days after the procedure. Pain relief was defined as a drop of at least 50% in VAS. The sample was chosen from the patients that came to Instituto Colombiano del Dolor in Medellin city for pain consultation from May through December 2011 and met the inclusion and exclusion criteria. The data were collected form primary sources.
The inclusion criteria were the following: (1) diagnosis of chronic pain (>6 months of evolution); (2) undergoing a single peripheral nerve or intra-articular block, and (3) use of ultrasonography to guide the block.
The exclusion criteria were (1) indication for interventional management with multiple simultaneous blocks; (2) pain management with prolotherapy, radiofrequency or ultrasound-guided trigger points; (3) continued perineural infusion catheter insertion, and (4) able to quantify the pain intensity.
The variables analyzed were gender--defined as phenotype, age in years at the time of the procedure; the type of procedure performed--the indication of the intervention to be made; the diagnosis of fibromyalgia present at the time of the procedure; the use of concomitant oral medicines--i.e., receiving acetaminophen in the last month--; a weak opioid; a tricyclic antidepressant and/or anti-neuropathic (pregabaline, gabapentin or carbamazepine); the pain score in terms of the subjective pain evaluation by the patient according to VAS and complications such as the occurrence of adverse events resulting from the intervention.
The database was stored in Microsoft Excel[R] and the software used for the analysis of the information was SPSS 18 (licensed by CES University). A descriptive analysis was completed for all the variables studied, supported by the calculation of proportions and descriptive measurements. The association between the quantitative variables and Pearson's Chi-square test was also established, in addition to a paired analysis to establish the difference between pain intensity before and after the procedure, using Wilcoxon's test. The association between pain relief with a diagnosis of fibromyalgia and the concomitant use of oral medicines was evaluated using Pearson's Chi-square test and the relative risks were calculated. A <5% statistical significance was used, with 95% confidence intervals.
A total of 426 ultrasound-guided interventional analgesic procedures were completed at Instituto Colombiano del Dolor, Medellin city, from May through December 2011. 152 patients were dismissed because they had undergone multiple procedures, 15 for radiofrequencies, 15 for prolotherapies, 46 for trigger points, 10 for perineural continuous infusion catheters and 39 because they had difficulty in quantifying pain. A total of 149 patients undergoing ultrasound-guided peripheral nerve block were analyzed.
Table 1 summarizes the general characteristics of the patients evaluated. Prior oral treatment corresponds to the treatment received in the last month, with at least acetaminophen, a mild opioid, a tricyclic antidepressant and/or an anti-neuropathic drug (pregabaline, gabapentin or carbamazepine).
The primary block performed was the supra-scapular nerve, followed by the saphenous, the sacroiliac, the stellate ganglion, ilioinguinal, lateral femoral cutaneous and femoral. The intra-articular blocks were the knee, the shoulder, the elbow, the sacroiliac and the sternochondral joints. To a lesser extent, there were other blocks such as cervical facets, medial lumbar ramus, sciatic, obturator, posterior tibial, medial, cubital, axillary, genitofemoral, greater occipital and the rectus sheath. The most important percentages are shown on Fig. 1.
The percentage of patients that experienced pain reduction after two days and after one month of the procedure were 79.2% and 38.9%, respectively.
The mean VAS score on the second day and after one-month follow-up was 2 and 6, respectively. The difference between the initial VAS and the second day means was 8, a statistically significant difference (p < 0.0001). Similarly, statistically significant differences were found between the initial and one-month VAS means (p< 0.0001). The pain intensity after one month of the procedure was higher on the second day but it was still less than before the block (Fig. 2).
In the sub-group analysis, equal results were found in the comparison of the pain intensity among patients with fibromyalgia and those who had not been receiving pharmacological treatment. In terms of the final result after two days and after one month of the block, there was no association between gender, a diagnosis of fibromyalgia and pain relief in both evaluation periods, or with having received treatment (Table 2).
[FIGURE 2 OMITTED]
The incidence of complications was 2.6%, one case of intramuscular hematoma (0.6%) and three (2%) patients that fell at home on the same day of the procedure because of a lower limb motor block.
There are few reports on the management of benign chronic pain, whilst there are many about malignant pain and perioperative regional anesthesia. Ultrasound-guided nerve blocks have been an effective and safe tool. This trial shows that pain relief was accomplished in 79.2% of the patients two days after the procedure and in 38.9% after one month of treatment with a low incidence of complications.
The most frequent block was the supra-scapular nerve block--the most sensitive nerve of the shoulder. This approach has been effective, particularly in rheumatoid arthritis, osteoarthritis, and rotator cuff disorders, with complications such as pneumothorax, intravascular injection, residual block and local trauma. (7) This trial included 34 supra-scapular blocks with a 79.4% efficacy after two days of the procedure and 35.3% after one month. There were no complications. A recent publication reported a 47.8% pain improvement in patients during the first month following the procedure. (8) Harmon and Hearty (9) reported a case of ultrasound-guided supra-scapular nerve block with a reduction in pain intensity and improved shoulder movement and function for 12 weeks. It is also possible to use continuous supra-scapular nerve block with a catheter, (10) but this approach is beyond the scope of this trial.
The saphenous nerve is a sensitive branch of the femoral nerve; it is easy to identify and its block provides analgesia in patients with chronic knee pain. The saphenous nerve innervates an extensive skin area on the medial aspect of the knee, the leg, the ankle and the foot, (11-15) in addition to improving acute postoperative pain. (16,17) Tsai et al. (18) reported a series of 39 cases of ultrasound-guided saphenous nerve blocks with a 77% success rate after four months; these results are similar to the results herein.
The ilioinguinal nerve block has been used to control postoperative pain mainly in inguinal herniorrhaphy in children, (19) but the procedure has been extended to adult patients in whom the incidence of postoperative inguinal pain is 12%. More recently it has also been used for managing chronic central sensitization pain. (20) This trial included 13 patients treated with ilioinguinal nerve block, of which after the second day only one patient continued to experience pain and after one month follow-up 61.5% were still improving.
Neck and chest blocks may have a high risk of esophageal, tracheal, and thyroid injury, intravascular or epidural injection and pneumothorax if not performed under real time visualization. Kapral et al. (21) described the ultrasound-guided stellate ganglion block in 1995, while the intercostal nerve block technique was described in 2004 by Eichenberger et al. (22) A high frequency transducer was used in this trial that enabled the identification of these structures and adequate positioning of the needle; (23) 13 stellate ganglion blocks were performed and there were no complications. Likewise, five intercostal blocks were administered with no pneumothorax reports, but there was one episode of hematoma in the dorsal paravertebral musculature reported 24 h after the block, in a patient that was anti-coagulated up to five days before the procedure. The patient received medical treatment and there were no sequels later.
Intra-articular blocks are traditionally performed "blindly", but ultrasonography is increasingly being used to be able to approach any joint. (6) 6% of our intra-articular blocks were in the shoulder and the knee with good results.
Due to the few chronic pain management reports, the recommendations are low evidence, except for the celiac plexus block, (1) for which the ultrasound-guided technique was described in 1983. (24) Cochrane published recently a systematic review (4) with 18 clinical trials and 1344 acute pain patients and reported an incidence of minor complications below 10%--a higher value than the number reported in this trial with one hematoma and three falls due to residual motor block of a lower limb, following a femoral block. The risk of falling after a lower limb block is high. (25) Muraskin et al., (26) reported two cases of falls following peripheral nerve blocks.
The limitations described were a short follow-up period and the possible bias of the patients' memory when retrospectively rating pain 48 h after the block.
The data contribute valuable information for the specialists in the area because of the broad range of ultrasound-guided blocks performed at a pain management referral center, with favorable and safe results. The blocks excluded from the trial are also relevant and should be the object of future research.
Ultrasonography-guided interventional pain management is a treatment option indicated for acute or chronic pain patients. This approach does not replace fluoroscopy-guided procedures, but offers some benefits such as lower cost, no radiation exposure and a lower rate of complications. All of the above considerations make this an effective and safe choice.
Received 20 October 2013
Accepted 3 September 2014
Available online 13 May 2015
Conflicts of interest
The authors have no conflicts of interest to declare.
The authors declare that they have followed the protocols of their work center on the publication of patient data Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study. Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.
(1.) Gofeld M. Ultrasonography in pain medicine: a critical review. Pain Pract. 2008;8:226-40.
(2.) Partownavid P. Ultrasound-guided peripheral nerve block. Am J Ther. 2009;16:304-12.
(3.) Koscielniak-Nielsen ZJ. Ultrasound-guided peripheral nerve blocks: what are the benefits? Acta Anaesthesiol Scand. 2008;52:727-37.
(4.) Walker KJ, McGrattan K, Aas-Eng K, Smith AF. Ultrasound guidance for peripheral nerve blockade. Cochrane Libr. 2011:1-64.
(5.) Marhofer P Willschke H, Kettner S. Current concepts and future trends in ultrasound-guided regional anesthesia. Curr Opin Anaesthesiol. 2010;23:632-6.
(6.) Murray JM, Derbyshire S, Shields MO. Lower limb blocks. Anaesthesia. 2010;65 Suppl. 1:57-66.
(7.) Chan ChW, Pen PWH. Suprascapular nerve block a narrative review. Reg Anesth Pain Med. 2011;36:358-73.
(8.) Arcila MA, Rivera RC, Campuzano D, Mejia MA, Martinez SM. Efficacy and safety of ultrasound-guided suprascapular nerve block in patients with chronic shoulder pain. Rev Colomb Anestesiol. 2013;41:104-8.
(9.) Harmon D, Hearty C. Ultrasound-guided suprascapular nerve block technique. Pain Physician. 2007;10:743-6.
(10.) Borglum J, Bartholdy A, Hautopp H, Krogsgaard MR, Jensen K. Ultrasound-guided continuous suprascapular nerve block for adhesive capsulitis: one case and a short topical review. Acta Anaesthesiol Scand. 2011;55:242-7.
(11.) Akkaya T, Ersan O, Ozkan D, Sahiner Y, Akin M, Gumus H, et al. Saphenous nerve block is an effective regional technique for post-menisectomy pain. Knee Surg Sports Traumatol Arthrosc. 2008;16:855-8.
(12.) Horn JL, Pitsch T, Salinas F Benninger B. Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade. Reg Anesth Pain Med. 2009;34:486-9.
(13.) Saranteas T, Anagnostis G, Paraskeuopoulos T, Koulalis D, Kokkalis Z, Nakou M, et al. Anatomy and clinical implications of the ultrasound guided subsartorial saphenous nerve block. Reg Anesth Pain Med. 2011;36:399-402.
(14.) Manickam B, Perlas A, Duggan E, Brull R, Chan VW, Ramlogan R. Feasibility and efficacy of ultrasound-guided block of the saphenous nerve in the adductor canal. Reg Anesth Pain Med. 2009;34:578-80.
(15.) Arcila MA, Rivera R, Mejia MA, Jaramillo S. Eficacia y seguridad del bloqueo del nervio safeno guiado por ultrasonido en pacientes con dolor cronico de rodilla. Rev Colomb Anestesiol. 2014;42:166-71.
(16.) Lundblad M, Kapral S, Marhofer P, Lonnqvist PA. Ultrasound-guided infrapatellar nerve block in human volunteers: description of a novel technique. Br J Anaesth. 2006;97:710-4.
(17.) Lund J, Jenstrup MT, Jaeger P Sorensen AM, Dahl JB. Continuous adductor-canal-blockade for adjuvant postoperative analgesia after major knee surgery: preliminary results. Acta Anaesthesiol Scand. 2011;55:14-9.
(18.) Tsai PB, Karnwal A, Kakazu C, Tokhner V. Julka IS. Efficacy of an ultrasound-guided subsartorial approach to saphenous nerve block: a case series. Can J Anaesth. 2010;57:683-8.
(19.) Willschke H, Marhofer P, Bosenberg A, Johnston S, Wanzel O, Cox SG, et al. Ultrasonography for ilioinguinal/iliohypogastric nerve blocks in children. Br J Anaesth. 2005;95:226-30.
(20.) Suresh S, Patel A, Porfyris S, Ryee MY. Ultrasound-guided serial ilioinguinal nerve blocks for management of chronic groin pain secondary to ilioinguinal neuralgia in adolescents. Paediatr Anaesth. 2008;18:775-8.
(21.) Kapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anaesth. 1995;20:323-8.
(22.) Eichenberger U, Greher M, Curatolo M. Ultrasound in interventional pain management. Tech Reg Anesth Pain Manag. 2004;8:171-8.
(23.) Narouze S. Ultrasonography in pain medicine: a sneak peak at the future. Pain Practice. 2008;8:223-5.
(24.) Greiner L, Ulatowski L, Prohm P. Sonographically guided and intraoperative alcohol block of de celiac ganglia in conservatively uncontrollable cancer induced epigastric pain. Ultraschall Med. 1983;4:57-9.
(25.) Fingermana M, Benonisb JG, Martin G. A practical guide to commonly performed ultrasound- guided peripheral-nerve blocks. Curr Opin Anaesthesiol. 2009;22:600-7.
(26.) Muraskin SI, Conrad B, Zheng N, Morey TE, Enneking FK. Falls associated with lower-extremity nerve blocks a pilot investigation of mechanisms. Re Anesth Pain Med. 2007;32:67-72.
Mario Andres Arcila-Lotero (a), Maria Adelaida Mejia-Aguilar (b), *
(a) Anesthesiologist, Professor of Anesthesia and Pain, Master in Epidemiology, CES University, Instituto Colombiano del Dolor, Colombia
(b) Physician, Instituto Colombiano del Dolor, Master in Epidemiology, CES University, Medellin, Colombia
** Please cite this article as: Arcila-Lotero MA, Mejia-Aguilar MA. Eficacia y seguridad del manejo intervencionista guiado por ultrasonografia en pacientes con dolor cronico: seguimiento a una cohorte. Rev Colomb Anestesiol. 2015;43:263-268.
* Corresponding author at: Instituto Colombiano del Dolor, Carrera 48 # 19 A--40, Medellin, Colombia.
E-mail address firstname.lastname@example.org (M.A. Mejia-Aguilar).
Table 1--Overall characteristics of the patients evaluated. Variable n = 149 Age in years (SD) 52(16.2) Female gender 71.8% Oral treatment in the past month 79.2% Diagnosis of fibromyalgia 18% Pain intensity (VAS mean) 10 SD, standard deviation; VAS, visual analog scale. Source: Authors. Table 2--Association of sex, fibromyalgia, oral pharmacological therapy and pain relief. Comparison RR 95% CI P-value Sex versus 2-day relief 0.8 0.3-2.1 0.7 Sex versus one-month relief 1.2 0.5-2.5 0.6 Fibromyalgia versus 2-day relief 1.5 0.7-3.1 0.2 Fibromyalgia versus 1-month relief 0.8 0.5-1.2 0.2 Oral treatment versus 2-day relief 1.4 0.5-3.6 0.4 Oral treatment versus 1-month relief 1.7 0.7-4 0.2 Source: Authors. Fig. 1--Frequency distribution of ultrasound-guided blocks. Suprascapular 22.8% Saphenous 11.4% Lateral femorocutaneous 5.3% Ilioinguinal 8,7% Scroiliac 9.4% Femoral 5.3% Intercostal 3.3% Stellate ganglion 8.7% Stellate ganglion 6% Others 18.7% Source: Authors. Note: Table made from bar graph.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Scientific and Technological Research|
|Author:||Arcila-Lotero, Mario Andres; Mejia-Aguilar, Maria Adelaida|
|Publication:||Revista Colombiana de Anestesiologia|
|Date:||Oct 1, 2015|
|Previous Article:||Bloqueo ganglio estrellado guiado por ultrasonografia.|
|Next Article:||Ecografia al lado de la cama del paciente para anestesiologos.|